VERACYTE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.37 USD | -0.76% |
|
+16.15% | -15.05% |
| 07/05 | Earnings Flash (VCYT) VERACYTE Posts Q1 Revenue $96.8M, vs. Street Est of $93.4M | MT |
| 07/05 | Transcript : Veracyte, Inc., Q1 2024 Earnings Call, May 07, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VERACYTE, INC. | Bio Diagnostics & Testing | -0.76% | +16.15% | -15.05% | -6.89% | -5.04% | 1.8B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- VCYT Stock
- Charts Veracyte, Inc.
- Comparison Chart